
Consultation begins into Dogger Bank wind farm extension plans
The project is an extension to the 277-turbine Dogger Bank Wind Farm, which is currently in construction and, when complete, will generate up to 3.6GW of electricity, enough to power four-and-a-half million homes. SSE said Dogger Bank D would produce up to 2GW of additional power.Plans include a subsea cable to export power from the wind farm to a landfall point near Skipsea. From there, underground cables would transmit the electricity 55km (34 miles) to a new substation called Birkhill Wood, which is being developed near Cottingham.
The consultation into the plans includes two online sessions and six in-person events, taking place on the following days:Tuesday 24 June, 15:00 to 18:30 BST: Skipsea Village HallWednesday 25 June, 14:00 to 19:00: Leven Sports HallThursday 26 June, 10:00 to 14:00: Cottingham Civic Hall Thursday 26 June, 15:00 to 18:00: Walkington Village HallFriday 27 June, 10:00 to 14:00: Toll Gavel Church Hall, BeverleySaturday 28 June, 10:00 to 14:00: Beverley Memorial HallSophie Large, senior project manager for Dogger Bank D, said: "We are looking forward to welcoming the public to our consultation events for Dogger Bank D and providing the opportunity for the community to learn more about our proposals. "It's important to us that local communities share their deep knowledge of the region and continue to review, and be informed about, our plans."SSE Renewables and Equinor said they would use the feedback from the consultation in its final application for a Development Consent Order, which would have to be approved by the government.The plans are also subject to a final investment decision by the developers.Listen to highlights from Hull and East Yorkshire on BBC Sounds, watch the latest episode of Look North or tell us about a story you think we should be covering here.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Reuters
6 minutes ago
- Reuters
China's Bio-Thera Solutions licenses its arthritis drug to Germany's STADA
HONG KONG, Aug 21 (Reuters) - China's Bio-Thera Solutions ( opens new tab said on Thursday it has granted Germany's STADA Arzneimittel commercialisation rights for its arthritis drug BAT1806, opens new tab in the EU, UK, Switzerland, certain Middle East and North Africa regions, and certain members of the Commonwealth of Independent States. Upfront payment and milestone payments will total up to 136 million euros ($158.34 million), including an 8.5 million euro down payment, milestone payments up to 127.5 million euros, and a double-digit percentage of net sales as revenue sharing, the Shanghai-listed firm said in a stock exchange filing, opens new tab. ($1 = 0.8589 euros)


Daily Mail
36 minutes ago
- Daily Mail
REVEALED: The forgotten clause that could now force Sir Jim Ratcliffe out of Man United - and what it means for the Glazers, Qataris and new owners
Last Wednesday, Manchester United crept back onto the market. It may well have passed by relatively unnoticed, but August 13 was a technically-significant date for the Premier League giants.


Reuters
36 minutes ago
- Reuters
China's Bio-Thera Solutions signs licensing deal with Germany's STADA for BAT1806 injection
HONG KONG, Aug 21 (Reuters) - China's Bio-Thera Solutions ( opens new tab on Thursday said it has signed an agreement granting Germany's STADA Arzneimittel commercialisation rights for its BAT1806 injection in the EU, UK, Switzerland, certain Middle East and North Africa regions, and certain members of the Commonwealth of Independent States. Upfront payment and milestone payments will total up to 136 million euros ($158.34 million), including an 8.5 million euro down payment, milestone payments up to 127.5 million euros, and a double-digit percentage of net sales as revenue sharing, the Shanghai-listed firm said in a stock exchange filing, opens new tab. ($1 = 0.8589 euros)